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Implicate Novel Genes in Neurodevelopment
Copy-number variation (CNV) across the genome has now
been identified in thousands of individuals with neurode-
velopmental issues. Although the role of many individual
CNVs in these phenotypes is certain, the pathogenicity of
others remains unclear, largely because of their rarity. With
a massive sample of nearly 50,000 cases and controls, Coe
et al. cement the role of several CNVs in neurodevelop-
mental disease and identify 14 new genomic regions for
which CNVs are overrepresented in cases compared to
controls. For many CNVs, it has not been possible to deter-
mine the true phenotype-causing culprit among the genes
encompassed by the variant. Hypothesizing that deletions
and de novo truncating mutations would yield the same
outcome on gene function, Coe et al. integrated their
CNV data with exome and targeted resquencing data to
zero in on the most relevant individual genes in each.
Loss-of-function changes are enriched in the case popula-
tion in ten of the genes analyzed. For two of these
genes, SETBP1 and ZMYND11, the authors present detailed
information on individuals with loss of function in the
gene and thereby define two new haploinsufficiency
syndromes.
Coe et al. (2014). Nature Genetics 46, 1063–1071.
Fly Screens to Disease Genes
In another example of large-scale data integration,
Yamamoto et al. did a chemical mutagenesis screen of
Drosophila to isolate essential X-linked genes that impact
neurodevelopment. They mapped 165 genes, including
many whose function has not been well studied. Next,
they compared these genes to exome data from more
than 1,900 people with undiagnosed, presumably Mende-
lian, conditions and were able to identify likely patho-
genic variants in six cases. These included known
OMIM phenotypes, expanded phenotypes associated
with known disease genes, and a novel microcephaly
gene.
Yamamoto et al. (2014). Cell 159, 200–214.
Decision-Support Guide Reduces Prenatal Genetic
Testing
The variety of available prenatal screening and testing op-
tions can be confusing to women, and it can be chal-
lenging for physicians to fully inform their patients of all1Department of Human Genetics, Emory University School of Medicine, Atlan
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decisions. To overcome these challenges, Kuppermann
et al. developed a computerized, interactive decision-sup-
port tool that describes the options in detail and provides
information on Down syndrome and other relevant condi-
tions. In a randomized trial, the researchers assessed
whether use of this tool and removal of financial barriers
to prenatal screening and testing influenced women’s deci-
sion making. Despite the fact that the testing would be
provided at no cost in the intervention group, women
who used the decision-support tool were less likely to
have invasive diagnostic testing and were more likely to
forgo prenatal screening and testing altogether. They
were also better able to answer questions about the risks
associated with amniocentesis and the risk of having a
baby with Down syndrome, suggesting that they made
more informed decisions about prenatal screening and
testing.
Kuppermann et al. (2014). J. Am. Med. Assoc. 312, 1210–
1217.
Led Astray
Animal models have undoubtedly been of vast benefit in
our attempts to understand basic human biology. Despite
evolutionary conservation, though, what we observe in
these models may not necessarily hold true in humans.
Ghezraoui et al. recently uncovered such an example
while studying the mechanism of chromosome transloca-
tions. In mice, the canonical nonhomologous end-joining
(c-NHEJ) pathway suppresses translocation formation
when there are double-stranded breaks. In mouse cells
deficient for a component of c-NHEJ, translocations occur
at increased frequency. In diametric opposition, deficiency
for the homologous pathway in human cells leads to
reduced translocation frequency when there are double-
stranded chromosome breaks, suggesting that c-NHEJ
is the main source of translocations. Examination of the
translocation junctions in these c-NHEJ-deficient cells
yields signatures of the alternate NHEJ pathway, the trans-
location-generating mechanism that typically predomi-
nates in mouse cells. Although both repair systems are
present in humans and in mice, research on mouse
cells alone would have led researchers astray as they
attempted to understand the generation of oncogenic
translocations.
Ghezraoui et al. (2014). Molecular Cell 55, 829–842.ta, GA 30322, USA
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Genotype-Guided Treatment of Type 2 Diabetes
One of the pie-in-the-sky uses for genome-wide association
studies is to go beyond the understanding of genetic con-
tributions to disease risk and personalize treatment on
the basis of these genetic risks. A small randomized trial
by Tang et al. hints that this might actually be plausible.
Intrigued by the association of type 2 diabetes with a
SNP in the gene for the a2A-adrenergic receptor, ADRA2A,
the researchers assessed the effect of a receptor antagonist,476 The American Journal of Human Genetics 95, 475–476, Novembyohimbine, on insulin secretion in individuals with the
risk genotype. This treatment increased insulin secretion
in individuals with the ADRA2A risk allele but did not
have a significant effect in the group without the allele.
Beyond the importance for personalized medicine,
this work also further supports the link between excess
a2A-adrenergic receptor activity and impaired insulin
secretion.
Tang et al. (2014). Sci. Trans. Med. 6, 257ra139.This Month in Our Sister JournalA SNP or Not a SNP?
Some of the high-throughput methods of SNP discovery,
such as genotyping by sequencing and restriction-site-
associated DNA sequencing, are relatively inexpensive
ways to find thousands of SNPs; they are also fraught
with error. To address this challenge, Chen et al. developed
a filtering method that is based on genotypes from nuclear
families. This framework uses Mendelian inheritance pat-
terns to assess errors. It also allows the identification ofsex-linked SNPs in organisms that may not have good
reference-genome information. The method is imple-
mented in the software MendelChecker and is a comple-
mentary approach to filtering genotyping data on the basis
of Hardy-Weinberg equilibrium. With as few as ten trios,
the method performs well and can improve quality control
during SNP discovery.
Chen et al. (2014). Genetics. Published online September 5,
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